Picture this: a leading healthcare powerhouse in the UAE just boosted its nine-month profits by a solid 8%, hitting Dh1.55 billion, all thanks to a bold global expansion strategy. But here's where it gets intriguing—what if this international push is reshaping healthcare as we know it, or could it be stirring up debates about prioritizing profits over patient care? Stick around, because we're diving into the details of PureHealth's latest achievements, and trust me, there's more to unpack than meets the eye.
Based in Abu Dhabi, PureHealth recently shared its financial results for the nine months ending September 30, 2025, showing how steady demand in its healthcare and insurance divisions, plus growing contributions from overseas operations, fueled the growth. The company's revenue climbed 6% from the previous year to Dh20.1 billion, with both its Care and Cover segments playing key roles. EBITDA— that's earnings before interest, taxes, depreciation, and amortization, a measure of operational profitability—jumped 11% to Dh3.5 billion, while net profit saw that impressive 8% rise we mentioned.
Kamal Al Maazmi, the Chairman of PureHealth, emphasized the group's commitment to growth and better outcomes. 'We're dedicated to scaling up while enhancing results,' he stated. 'With our moves into new international markets and investments in clinical and digital tools, we're setting ourselves up to build a healthcare platform ready for the future.' It's a clear vision, isn't it? But this is the part most people miss: how does expanding globally truly impact local communities in the UAE or elsewhere?
And now, let's talk about the elephant in the room—their expansion into Europe. In a major move during the third quarter, PureHealth acquired the Hellenic Healthcare Group, bringing on board 11 hospitals and 23 diagnostic centers spread across Greece and Cyprus. This deal bumps up the percentage of their assets outside the UAE to 52%, helping them create a more varied healthcare network. Fully financed through their own balance sheet, the acquisition is set to start contributing to earnings from October 1, 2025. Plus, it opens doors for wider clinical reach, research collaborations, sharing of operational expertise, and integrating digital systems across different regions. For beginners wondering about this, think of it like adding branches to a tree—each new limb strengthens the whole, allowing for better sharing of resources and knowledge in healthcare.
Shaista Asif, the Group CEO, highlighted how this success stems from excellent execution. 'Our growth comes from strong performance in both Care and Cover areas, with more patient interactions, increased diagnostic work, and solid insurance renewals,' she explained. 'Adding Hellenic Healthcare Group is a game-changer for our worldwide abilities.' It's exciting to see, but here's where controversy brews: is acquiring foreign hospitals about genuine care expansion, or is it more of a corporate strategy to tap into new profit streams? Opinions might divide here.
Diving deeper into the Care segment, revenue grew 3% year-over-year to Dh14.4 billion. Patient engagements surged notably in both UAE and UK operations. In the UAE, outpatient visits rose 16%, inpatient stays increased 12%, lab tests climbed 20%, and surgeries went up 16%. Hospital bed occupancy there even improved to 73%, indicating busier facilities. Meanwhile, in the UK, they saw boosts in inpatient admissions, day-case procedures, and outpatient visits in specialties like orthopaedics, cardiology, general medicine, and oncology. Imagine, for example, someone with a heart condition getting faster access to cardiology services— this kind of growth can mean life-saving improvements for patients.
On the insurance front, the Cover segment kept the momentum going strong, with revenue jumping 13% to Dh5.7 billion. Membership numbers increased 7% to 3.3 million, driven by new product introductions, high customer loyalty, and broader coverage areas. Gross written premiums—a key metric for insurance companies, showing the total value of policies issued—reached Dh5.9 billion. Their subsidiary, Daman, kept innovating too, automating claims processes and rolling out an AI-powered document system that now manages over 60 million documents annually, boosting accuracy and speed. For those new to this, it's like having a super-smart assistant handling paperwork effortlessly, reducing errors and freeing up time for what matters most: helping people.
So, there you have it—PureHealth's story of growth, acquisitions, and innovation. But let's stir the pot a bit: with profits soaring on global moves, is this the right path for healthcare, or are we overlooking potential downsides like cultural clashes in new markets or the ethics of profit-driven expansions? What do you think—does scaling internationally make healthcare better for everyone, or should companies focus more locally? We'd love to hear your thoughts in the comments—agree or disagree, let's discuss!
